Can Macrobid (nitrofurantoin) and Bactrim (trimethoprim/sulfamethoxazole) be used together in a patient with a urinary tract infection?

Can Macrobid and Bactrim Be Used Together?

No, Macrobid (nitrofurantoin) and Bactrim (trimethoprim-sulfamethoxazole) should not be used together for urinary tract infections, as there is no clinical benefit to combination therapy and it unnecessarily increases the risk of adverse effects without improving outcomes. 1, 2

Rationale Against Combination Therapy

Both agents are effective as monotherapy for uncomplicated lower UTIs, and guidelines consistently recommend single-agent treatment rather than combination approaches. 3, 2, 4

• For uncomplicated cystitis in women, first-line options include nitrofurantoin 100 mg twice daily for 5 days OR trimethoprim-sulfamethoxazole 160/800 mg twice daily for 3 days—used individually, not together 2, 4
• The WHO Essential Medicines recommendations list both as separate treatment options for lower UTIs, with amoxicillin-clavulanate as first choice and nitrofurantoin as second choice 1
• Multiple high-quality guidelines from IDSA/ESCMID, AUA/CUA/SUFU, and American College of Physicians recommend these agents as alternatives to each other, not as combination therapy 3, 2

Evidence Supporting Monotherapy

Systematic reviews demonstrate equivalence between these agents when used individually, with no data supporting combination use: 1

• Nitrofurantoin versus trimethoprim-sulfamethoxazole showed no difference in short-term (RR 0.99,95% CI 0.95-1.04) or long-term (RR 1.01,95% CI 0.94-1.09) symptomatic cure rates 1
• Both agents achieve high urinary concentrations and are active against common uropathogens (except Pseudomonas and Serratia) 5

Risks of Unnecessary Combination

Using both agents simultaneously exposes patients to additive adverse effects without therapeutic benefit: 3, 2

• Nitrofurantoin carries risks of pulmonary toxicity (0.001%) and hepatic toxicity (0.0003%), plus common GI disturbances and rash 3
• Trimethoprim-sulfamethoxazole causes skin eruptions in up to 12% of patients (often appearing on day 7 or later), plus GI symptoms 6
• Combining agents doubles the risk profile without improving cure rates above 90% achieved with monotherapy 6

When Each Agent Should Be Used Alone

Choose ONE agent based on local resistance patterns, patient factors, and infection type: 2, 4

Nitrofurantoin (5 days):

• Preferred when local TMP-SMX resistance exceeds 20% 2, 4
• Contraindicated in pyelonephritis (inadequate tissue concentrations) and G6PD deficiency 7
• Should not be used in patients with CrCl <30 mL/min 7

Trimethoprim-Sulfamethoxazole (3 days):

• Appropriate when local resistance is <20% 2, 4
• Must be discontinued immediately if Aerococcus urinae is identified, as this organism has intrinsic sulfonamide resistance 8
• More cost-effective than nitrofurantoin but higher resistance rates in many regions 5

Critical Exception: Aerococcus Urinae

If culture results reveal Aerococcus urinae, Bactrim must be stopped immediately due to inherent resistance, and the patient should be switched to amoxicillin or nitrofurantoin based on susceptibilities 8

• IDSA guidelines mandate discontinuing TMP-SMX for Aerococcus infections due to treatment failure risk 8
• Switch to amoxicillin 500 mg three times daily for 5-7 days or nitrofurantoin 100 mg twice daily for 5 days 8

Antibiotic Stewardship Considerations

Using a single appropriate agent aligns with antimicrobial stewardship principles: 3, 2

• Shorter courses with single agents reduce adverse events and antimicrobial resistance 2
• Treatment duration should be the minimum effective: 3 days for TMP-SMX, 5 days for nitrofurantoin 2, 4
• Reserve fluoroquinolones for resistant organisms or treatment failures, not empiric combination therapy 2